Menu

Scalp Microbiome Linked to Dandruff Severity

Researchers identify differences in the composition of microbial species living on the scalps of people with different levels of dandruff.

May 12, 2016
Catherine Offord

WIKIMEDIA, HMOCHOA95Dandruff affects about half of the postpubescent population, and previous studies have suggested that microbes living on the scalp are the main cause. Now, a team led by researchers at Shanghai Jiao Tong University, China, have found that the severity of dandruff is linked to the composition of those microbes—in particular, bacteria—offering potential opportunities for treatment. The findings were published today (May 12) in Scientific Reports.

Researchers have suggested a number of factors to explain the presence of dandruff, including the quantity of a natural oily substance called sebum secreted through a person’s skin, and the action of scalp-living Malassezia fungi that have been implicated in various forms of dermatitis. But sequencing the bacteria and fungi living in 174 scalp samples from 59 people with slight to moderate dandruff, the Shanghai researchers found that, in fact, the composition of bacterial species was more strongly associated with dandruff severity than the composition of fungal species. Some species, such as Staphylococcus, were linked to increased severity of dandruff, while others, such as Propionibacterium, showed some capacity to inhibit dandruff-associated bacteria.

Based on the findings, the authors suggest that controlling the composition of microbes living on a person’s scalp could provide potential treatment solutions for the condition. “The relationship between the severity of dandruff and the bacteria suggested that adjusting the equilibrium of the bacteria, particularly by increasing the Propionibacterium and decreasing the Staphylococcus on the scalp, might be a novel way to lessen the severity of dandruff,” they wrote in their paper.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.